VIWALA
Impact investorSeed–Growth
Find your way into VIWALA
Sign up to see every warm intro you have to VIWALA
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VIWALA team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
VIWALA provides debt financing to small and medium-sized enterprises that want to integrate positive-impact actions into their operations. Rather than offering capital alone, it combines debt instruments with tailored action plans designed to make adopting sustainable and inclusive practices simple and operationally efficient. The firm views SMEs as agile engines of change that can pivot quickly and lead the transition to a more sustainable and inclusive economy. Its credit products reward measurable impact, turning inclusion and sustainability commitments into real financial advantages. Specific offerings include credit for women entrepreneurs, credit for companies generating social or environmental impact, and credit for companies adopting inclusion and diversity practices.
Source: firm website, verified Oct 26, 2026.
Frequently asked questions
- What stage does VIWALA invest at?
- VIWALA invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does VIWALA focus on?
- VIWALA focuses on Impact & Social Good.
Similar investors
Cottonwood Technology Fund is an early-stage deep tech venture capital fund investing in patent-based hard science companies in the Southwest US and Northwest Europe.
Horizons Ventures is a venture capital firm investing in deep science and technology companies aiming to drive significant positive change for humanity.
Octopus Ventures is a founder-focused European venture capital firm that backs mission-driven startups across seven core sectors, investing from idea stage through growth with a focus on pre-seed to Series A.
Partech is a global venture capital firm supporting founders across multiple continents and investment stages through dedicated teams and funds.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.




